All Curated Mutation Sites in MCV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in MCV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
Large T
  
Small T
  
VP1
  
VP2
  

Keyword: Large T
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 34761184 D44N
Large T
MCPyV_gp3
Cell line
T
View
2 34761184 E216K
Large T
MCPyV_gp3
Cell line
T
View
3 35336880 C44A
Large T
MCPyV_gp3
Cell line
R
T
View
4 35336880 S147A
Large T
MCPyV_gp3
Cell line
R
T
View
5 35336880 W209A
Large T
MCPyV_gp3
Cell line
R
T
View
6 21454559 T205A
Large T
MCPyV_gp3
Cell line
T
View
7 21454559 G207A
Large T
MCPyV_gp3
Cell line
T
View
8 21454559 T208A
Large T
MCPyV_gp3
Cell line
T
View
9 21454559 E216K
Large T
MCPyV_gp3
Cell line
T
View
10 21454559 R204A
Large T
MCPyV_gp3
Cell line
T
View
11 21454559 W209A
Large T
MCPyV_gp3
Cell line
T
View
12 21454559 Y206A
Large T
MCPyV_gp3
Cell line
T
View
13 32962090 S220A
Large T
MCPyV_gp3
Cell line
R
View
14 32962090 S239A
Large T
MCPyV_gp3
Cell line
R
View
15 32962090 S147A
Large T
MCPyV_gp3
Cell line
R
View
16 32962090 S142A
Large T
MCPyV_gp3
Cell line
R
View
17 28461484 S220A
Large T
MCPyV_gp3

R
T
View
18 28461484 S239A
Large T
MCPyV_gp3

R
T
View
19 28461484 S147A
Large T
MCPyV_gp3

R
T
View
20 21501625 F391A
Large T
MCPyV_gp3

R
View
21 21501625 F391R
Large T
MCPyV_gp3

R
View
22 21501625 K331A
Large T
MCPyV_gp3

R
View
23 21501625 K331R
Large T
MCPyV_gp3

R
View
Contents
Description

The table shows all curated mutation sites of MCV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.